Is Cigna (CI) Stock Outpacing Its Finance Peers This Year?

CI

Investors focused on the Finance space have likely heard of Cigna (CI - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question.

Cigna is one of 866 individual stocks in the Finance sector. Collectively, these companies sit at #9 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. CI is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past 90 days, the Zacks Consensus Estimate for CI's full-year earnings has moved 3.48% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

Our latest available data shows that CI has returned about 7.26% since the start of the calendar year. Meanwhile, stocks in the Finance group have lost about 6.90% on average. As we can see, Cigna is performing better than its sector in the calendar year.

Looking more specifically, CI belongs to the Insurance - Multi line industry, a group that includes 27 individual stocks and currently sits at #110 in the Zacks Industry Rank. This group has lost an average of 14.57% so far this year, so CI is performing better in this area.

Investors with an interest in Finance stocks should continue to track CI. The stock will be looking to continue its solid performance.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>